NASDAQ$BTTC

Black Titan Corp · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Headline financials

Total Revenue

$0.00

Previous: $328.00-100.0%
EPS

-$0.62

Previous: -$1.24+50.3%
Capital Expenditures

$0.00

Previous: $0.00
Free Cash Flow

-$867K

Previous: -$613K-41.4%
Net Income

-$563K

Previous: -$314K-79.6%
Operating Income

-$534K

Previous: -$314K-70.3%
Gross Profit

$0.00

Previous: $328.00-100.0%
Cash & Equivalents

$1.95M

Previous: $6.16M-68.4%
Total Assets

$2.16M

Previous: $6.65M-67.6%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$0

Q1 2025-100%vs Q1 2024
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro